Defining the optimal formulation and schedule of a candidate toxoid vaccine against Clostridium difficile infection: A randomized Phase 2 clinical trial.
暂无分享，去创建一个
R. Gesser | M. van Cleeff | G. de Bruyn | Jamshid Saleh | D. Workman | R. Pollak | V. Elinoff | Neil J. Fraser | G. Lefebvre | M. Martens | R. Mills | Richard Nathan | M. Trevino | G. Foglia | A. Ozol-Godfrey | Dhaval Patel | P. Pietrobon | J. Saleh | Patricia J Pietrobon